CD1d expression on B-precursor acute lymphoblastic leukemia subsets with poor prognosis

Leukemia

Volumn 19, Issue 4, 2005, Pages 551-556

  Fais, Franco ^a   Tenca, C ^a   Cimino, G ^b   Coletti, V ^c   Zanardi, S ^a   Bagnara, D ^a   Saverino, D ^a   Zarcone, D ^a   De Rossi, G ^c   Ciccone, E ^a   Grossi, C E ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Acute lymphoblastic leukemia; CD1d; CD1d restricted T cells; Natural killer T cells; galactosylceramide

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CANCER SURVIVAL; CELL ISOLATION; CELL MATURATION; CHILD; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; FLOW CYTOMETRY; GENE EXPRESSION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; PHENOTYPE; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 20244383320     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403671     Document Type: Article

References (17)

1. Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia. N Engl J Med 2004; 350: 1535-1548.
2. Caligaris-Cappio F, Greaves MF, Grossi CE, Pistoia V. Lymphoproliferative disorders. In: Zucker-Franklin D, Grossi CE (eds). Atlas of Blood Cells. Function and pathology, Vol 2. Milan: Ermes, 2003, pp 567-661.
3. Eguchi M, Eguchi-Ishimae M, Greaves M. The role of the MLL gene in infant leukemia. Int J Hematol 2003; 78: 390-401.
4. Carroll WL, Bhojwani D, Min DJ, Raetz E, Relling M, Davies S et al. Pediatric acute lymphoblastic leukemia. Hematology (Am Soc Hematol Educ Program) 2003, 102-131.
5. Brigl M, Brenner MB. CD1: antigen presentation and T cell function. Annu Rev Immunol 2004; 22: 817-890.
6. Benlagha K, Weiss A, Beavis A, Teyton L, Bendelac A. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J Exp Med 2000; 191: 1895-1903.
7. Fais F, Morabito F, Stelitano C, Callea V, Zanardi S, Scudeletti M et al. CD1d is expressed on B-chronic lymphocytic leukemia cells and mediates alpha-galactosylceramide presentation to natural killer T lymphocytes. Int J Cancer 2004; 109: 402-411.
8. Elia L, Mancini M, Moleti L, Meloni G, Buffolino S, Krampera M et al. A multiplex reverse transcriptase-polymerase chain reaction strategy for the diagnostic molecular screening of chimeric genes: a clinical evaluation on 170 patients with acute lymphoblastic leukemia. Haematologica 2003; 88: 275-279.
9. Cimino G, Lo Coco F, Biondi A, Elia L, Luciano A, Croce CM et al. ALL-1 gene at chromosome 11q23 is consistently altered in acute leukemia of early infancy. Blood 1993; 82: 544-546.
10. Borkhardt A, Wuchter C, Viehmann S, Pils S, Teigler-Schlegel A, Stanulla M et al. Infant acute lymphoblastic leukemia - combined cytogenetic, immunophenotypical and molecular analysis of 77 cases. Leukemia 2002; 16: 1685-1690.
11. Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002; 30: 41-47.
12. Schwartz S, Rieder H, Schlager B, Burmeister T, Fischer L, Thiel E. Expression of the human homologue of rat NG2 in adult acute lymphoblastic leukemia: close association with MLL rearrangement and a CD10(-)/CD24(-)/CD65s(+)/CD15(+) B-cell phenotype. Leukemia 2003; 17: 1589-1595.
13. Marktel S, Magnani Z, Ciceri F, Cazzaniga S, Riddell SR, Traversari C et al. Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell-depleted stem cell transplantation. Blood 2003; 101: 1290-1298.
14. Takahashi T, Haraguchi K, Chiba S, Yasukawa M, Shibata Y, Hirai H. Valpha24+ natural killer T-cell responses against T-acute lymphoblastic leukaemia cells: implications for immunotherapy. Br J Haematol 2003; 122: 231-239.
15. Metelitsa LS, Weinberg KI, Emanuel PD, Seeger RC. Expression of CD1d by myelomonocytic leukemias provides a target for cytotoxic NKT cells. Leukemia 2003; 17: 1068-1077.
16. Nieda M, Okai M, Tazbirkova A, Lin H, Yamaura A, Ide K et al. Therapeutic activation of Valpha24+Vbeta11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. Blood 2004; 103: 383-389.
17. Giaccone G, Punt CJ, Ando Y, Ruijter R, Nishi N, Peters M et al. A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors. Clin Cancer Res 2002; 8: 3702-3709.